INH14 is primarily utilized in research settings, particularly in the study of neurodegenerative diseases. It is known for its role as an inhibitor of specific enzymes or pathways that are implicated in conditions such as Alzheimer's disease. By targeting these pathways, INH14 helps researchers understand the underlying mechanisms of neurodegeneration and evaluate potential therapeutic strategies. Additionally, it may be used in preclinical studies to assess its efficacy and safety as a candidate for drug development. Its application is crucial in advancing knowledge and treatment options for complex neurological disorders.